DERM Health Economics Study

CompletedOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

February 26, 2020

Primary Completion Date

August 5, 2021

Study Completion Date

August 6, 2021

Conditions
MelanomaNon-melanoma Skin Cancer
Interventions
DEVICE

Deep Ensemble for the Recognition of Malignancy (DERM)

AI-based decision support tool

Trial Locations (1)

SW10 9NH

Chelsea and Westminster Hospital, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Innovate UK

OTHER_GOV

lead

Skin Analytics Limited

INDUSTRY